Search Results 301-310 of 17008 for pharmacogenetics
Cholangiocarcinoma (CCA) is an aggressive cancer that forms in the cells that line the bile duct. The only treatment options include aggressive chemotherapy ...
Karter's journey of hope · Science Saturday: Potential new treatment for breast cancer metastasis featured image · Immune response to ovarian cancer may predict ...
The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...
Adedinsewo D, Dugan J, Johnson PW, Douglass EJ, Morales-Lara AC, Parkulo MA, Ting HH, Cooper LT, Scott LR, Valverde AM, Padmanabhan D, Peters NS, ...
Some of the most harmful genetic changes in cancer are also the hardest to see. These structural alterations, deep within a tumor's DNA, can fuel[...] ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.
The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...
"Dr. Dhamija was very helpful to me. She's the only one ever agree to run the test. We found something big. I have mitochondrial disease that has.
Pharmacogenetics in dermatology: a patient-centered update. Int J Dermatol. 2013 Aug; 52(8):1005-12. Epub 2013 Jun 20. View PubMed; Comfere NI, Gonzalez ...
March 8 is International Women's Day, and it's also Women's History Month, providing an opportunity to celebrate the achievements of women in science and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.